LogicBio Therapeutics Inc. appointed Richard Moscicki and Michael Wyzga as directors.

Moscicki is the executive vice president for science and regulatory advocacy and the chief medical officer at Pharmaceutical Research and Manufacturers of America.

Wyzga is the CEO and president of MSW Consulting Inc., a private biotechnology consulting firm.

LogicBio Therapeutics is a genome-editing company that develops medicines for rare diseases in patients with unmet medical needs.